Skip to main content

Table 2 Univariate logistic regression analysis of variables investigated for prediction of mortality in cancer patients with bloodstream infection

From: Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance

 

Alive (n = 324, 78.5%)

Dead (n = 89, 21.5%)

OR (95% CI)

p-value

Sex

 Female

136 (45.8)

37 (45.7)

1.005 (0.613,1.645)

0.986

 Male*

161 (54.2)

44 (54.3)

Age

  < 60

209 (70.4)

52(64.2)

1.325 (0.789,2.224)

0.288

  > 60*

88 (29.6)

29(35.8)

Malignancy type

 Solid organ tumor*

131 (44.1)

36 (44.4)

1.014 (0.618,1.662)

0.957

 Hematologic malignancy

166 (55.9)

45 (55.6)

 ESR

73.58 (36.10)

63.77 (36.88)

1.008 (0.999,1.017)

0.091

 CRP

82.12 (43.12)

88.36 (28.62)

0.996 (0.989,1.004)

0.332

WBC count

  < 4000/μl*

169 (57.3)

49 (60.5)

1.142 (0.691,1.885)

0.605

  > 4000/μl

126 (42.7)

32 (39.5)

Neutropenia

 Yes (< 1500/μl)

121 (41.3)

33 (41.3)

1.002 (0.606,1.656)

0.994

 No (> 1500/μl) *

172 (58.7)

47 (58.8)

Febrile neutropenia

 No

212 (71.4)

60 (74.1)

0.873 (0.500,1.524)

0.633

 Yes*

85 (28.6)

21 (25.9)

Year

 2015

36 (12.1)

6 (7.4)

1.773 (0.612,5.132)

0.291

 2016

52 (17.5)

11 (13.6)

1.397 (0.569,3.427)

0.466

 2017

81 (27.3)

22 (27.2)

1.088 (0.500,2.368)

0.832

 2018

84 (28.3)

29 (35.8)

0.856 (0.405,1.810)

0.684

 2019*

44 (14.8)

13 (16)

  

Enterobacterales

 No*

70 (36.1)

18 (38.3)

1.100 (0.570,2.121)

0.777

 Yes

124 (63.9)

29 (61.7)

  1. * Reference